RNA sequencing comparison of B7-H3.TMIGD2 and B7-H3.CD28.4-1BB CAR-T cells to CD19.CD28.4-1BB CAR-T cells in vitro
RNA-seq (gene expression) · human · 12 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 12 samples: 4 × B7H3_TMIGD2, invitro, Dono vs 4 × B7H3_CD28_41BB, invitro, Dono vs 4 × CD19, invitro, DonoGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE254546_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1071016 and SRA study SRP486797. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 12 samples.
How we read this: 3 replicated groups read from 12 sample titles; they account for 12 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8045736 B7H3_TMIGD2, invitro, Donor 1 B7H3_TMIGD2, invitro, D…
- GSM8045737 B7H3_TMIGD2, invitro, Donor 2 B7H3_TMIGD2, invitro, D…
- GSM8045738 B7H3_TMIGD2, invitro, Donor 3 B7H3_TMIGD2, invitro, D…
- GSM8045739 B7H3_TMIGD2, invitro, Donor 4 B7H3_TMIGD2, invitro, D…
- GSM8045740 B7H3_CD28_41BB, invitro, Donor 1 B7H3_CD28_41BB, invitro…
- GSM8045741 B7H3_CD28_41BB, invitro, Donor 2 B7H3_CD28_41BB, invitro…
- GSM8045742 B7H3_CD28_41BB, invitro, Donor 3 B7H3_CD28_41BB, invitro…
- GSM8045743 B7H3_CD28_41BB, invitro, Donor 4 B7H3_CD28_41BB, invitro…
- GSM8045744 CD19, invitro, Donor 1 CD19, invitro, Dono
- GSM8045745 CD19, invitro, Donor 2 CD19, invitro, Dono
- GSM8045746 CD19, invitro, Donor 3 CD19, invitro, Dono
- GSM8045747 CD19, invitro, Donor 4 CD19, invitro, Dono
- GSE254544 RNA sequencing comparison of B7-H3.TMIGD2 and B7-H3.CD28.4-1BB CAR-T cells in vitro 8 samples shares tmigd2, b7-h3, 4-1bb, car-t, cd28, comparison, vitro
- GSE254547 RNA sequencing comparison of B7-H3.TMIGD2 and B7-H3.CD28.4-1BB CAR-T cells 28 samples shares tmigd2, b7-h3, 4-1bb, car-t, cd28, comparison
- GSE254545 RNA sequencing comparison of B7-H3.TMIGD2 and B7-H3.CD28.4-1BB CAR-T cells in vivo. 8 samples shares tmigd2, b7-h3, 4-1bb, car-t, cd28, comparison
- GSE276932 Gene expression in self-activating CAR-T cells with CD28 or 4-1BB costimulatory domain and G4S or Whilow218 linker. 15 samples shares 4-1bb, car-t, cd28
- GSE267821 4-1BB causes CAR-T cell death via sequestration of the ubiquitin-modifying enzyme A20 22 samples shares 4-1bb, car-t
- GSE314992 Expression of the CXCR4 S338X variant improves anti-leukemia efficacy of anti-CD19 CAR-T cells 20 samples shares car-t, cd19
- GSE231429 Placental T cells retain enhanced stemness and altered cytokine response favoring durable efficacy of CD19 CAR-T 13 samples shares car-t, cd19
- GSE277818 Targeting PRC2 enhances the antitumor cytotoxic capacity of anti-CD19 CAR-T cells against hematological malignancies 12 samples shares car-t, cd19
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.